SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
In connection with the merger transaction, Oien was appointed as President and principal executive officer of Boundless Bio, replacing departing CEO Hornby, along with compensatory arrangements including transaction bonuses and acceleration of stock options.
View raw filing on EDGAR →Wendy's appointed Steven W. Cirulis as Chief Financial Officer and Chief Strategy Officer effective June 23, 2026, with a $675,000 base salary, 90% bonus target, and $1,650,000 annualized LTIP grant. Ken Cook departed the CFO role effective July 31, 2026, transitioning to an advisory capacity.
View raw filing on EDGAR →The filing discloses both a departure (James J. Lorenz retiring effective December 31, 2026) and an appointment (John T. Robson appointed Vice President – Energy Operations effective January 1, 2027). While both events are present, the principal forward-looking action and the substantive disclosure centers on the appointment of Robson to succeed Lorenz in a key operational role. The appointment is the material event that addresses continuity of leadership in Energy Operations.
View raw filing on EDGAR →The filing discloses both the departure of Nelson Haight as Executive Vice President and Chief Financial Officer and the appointment of Clinton Roeder to the same role, effective June 22, 2026. While both events are disclosed, the appointment of a new CFO with detailed compensation terms (base salary of $500,000, bonus target of 75%, and equity grants of approximately $500,000) is the forward-looking material event that would affect investor assessment of the company's leadership and financial management going forward. The appointment is the principal action the company is announcing to the market.
View raw filing on EDGAR →The Board appointed W. Bradley Southern as a director effective June 23, 2026, increasing authorized directors from 13 to 14. Mr. Southern brings extensive executive experience as former CEO and Chair of Louisiana-Pacific Corporation (1999–2026) and currently serves as chair of the Nashville Federal Reserve Bank branch.
View raw filing on EDGAR →Cory Anderson was promoted from Senior Vice President, Chief Technology Officer to Executive Vice President, General Manager of Greenbrook effective July 1, 2026. While the disclosure includes compensatory changes (salary increase to $425,000 and bonus target increase to 45%), the principal disclosed action is the promotion to a new executive officer role with expanded responsibilities. The appointment of a person to a higher executive position is the salient event, though the compensation component is secondary.
View raw filing on EDGAR →The filing discloses the appointment of Robert Azelby as a director of Tango Therapeutics, effective June 19, 2026, to fill a newly created board vacancy. While the disclosure also includes compensatory arrangements (equity awards and retainers), the principal action is the appointment itself. The appointment of an experienced biopharmaceutical executive with 30+ years of industry leadership to the board of a clinical-stage biotech company is material to investors assessing the company's governance and strategic direction.
View raw filing on EDGAR →The Board appointed Dr. Robert Wills as non-executive Chair of the Board following the June 16, 2026 annual meeting, a material change to the registrant's senior leadership structure.
View raw filing on EDGAR →The filing discloses the election of Li Shanglong (Michael Li) as new Chairman and the appointment of Shao Weizhi (Eric Shao) as new Chief Executive Officer, following the resignation of James Li from both CEO and Chairman roles. While the filing involves both a departure and appointments, the principal disclosed action centers on the appointment of two new senior executives to lead the company's strategic transformation. The detailed biographical information and Board's rationale for the appointments underscore their materiality to investors assessing leadership continuity and strategic direction.
View raw filing on EDGAR →The 6-K discloses the appointment of Kun Yang as an independent director and member of three board committees, including chair of the Corporate Governance and Nominating Committee, effective June 18, 2026. While the filing also mentions the concurrent resignation of Bin Wu, the principal disclosed action is the appointment of a new director to fill the vacancy. The appointment includes detailed biographical information and confirmation of independence under Nasdaq rules, indicating material governance significance.
View raw filing on EDGAR →The filing discloses the appointment of Jeffrey R. Geygan as a member of Loop Industries' Board of Directors, effective June 22, 2026. The Board increased its size by one seat specifically to accommodate this appointment. While the disclosure also mentions compensatory arrangements (5,170 restricted stock units), the principal disclosed action is the appointment itself, making exec_appointment the most salient classification. Board appointments are material to investors as they affect governance and oversight.
View raw filing on EDGAR →The filing discloses the appointment of Lukas Lutz as an independent director and member of the Nominating and Corporate Governance Committee, effective June 18, 2026, replacing Brian Nelson. The appointment includes a grant of 10,000 RSUs with staggered vesting and standard director compensation, which are material governance changes affecting board composition and leadership structure.
View raw filing on EDGAR →The filing discloses the appointment of Dr. Corazon (Corsee) Sanders to the Board of Directors as a Class III director effective June 17, 2026, and her concurrent appointment to the Audit Committee. The principal disclosed action is a person taking a role. Dr. Sanders is a highly experienced biotechnology executive with 30+ years of leadership at major firms (Genentech/Roche, Juno/Celgene/BMS) and currently serves on multiple public company boards, making her appointment material to investors assessing the company's governance and strategic direction.
View raw filing on EDGAR →The filing discloses the appointment of Kevin Miller as Executive Vice President, Chief Financial Officer and Treasurer, effective June 1, 2026, with an employment agreement dated June 18, 2026. While the agreement includes detailed compensation terms (base salary of $430,000, bonus eligibility, and equity awards), the principal disclosed action is the appointment of a named executive officer to a C-suite position. This is material to investors as it represents a significant leadership change in the company's financial management.
View raw filing on EDGAR →Wayne Tupuola, the President and CEO, took a three-month leave of absence for health reasons on June 16, 2026, and the Board appointed Ann Tewari, Executive Vice President of Global Operations and Strategy, as Interim President. While the filing discloses both a departure (Tupuola's leave) and an appointment (Tewari's interim role), the principal disclosed action centers on the appointment of interim leadership to fill the CEO vacancy during Tupuola's absence. This is material as it affects the registrant's executive leadership structure and investor assessment of operational continuity.
View raw filing on EDGAR →Robert Brackenbury was appointed to the Board of Directors of Athene Holding Ltd. as an independent director effective June 23, 2026. Brackenbury brings extensive experience as Deputy Chief Investment Officer of the State of Michigan Retirement System, where he oversaw $170 billion in assets, and brings expertise in retirement services and institutional investment management.
View raw filing on EDGAR →The filing discloses the appointment of Ron Philip to the Board of Directors of Avalo Therapeutics, effective June 23, 2026. The principal disclosed action is a person taking a role as director and committee member. While the disclosure includes compensatory arrangements (stock option grant of 40,200 shares), the core event is the appointment itself, making exec_appointment the most salient classification. Board appointments by experienced executives (Philip's background includes CEO roles at Spark Therapeutics and Orbital Therapeutics) are material to investors.
View raw filing on EDGAR →Cal-Maine Foods appointed two independent directors, Haley R. Fisackerly and Michael J. Highfield, to its Board of Directors effective June 23, 2026, expanding the Board from eight to ten directors. The new directors bring expertise in operations, infrastructure, finance, capital markets, and organizational leadership, and were assigned to three Board committees.
View raw filing on EDGAR →Adriano Duarte was appointed Executive Vice President and Chief Financial Officer of Provident Financial Services, Inc. and Provident Bank, effective July 1, 2026. Duarte brings over 30 years of banking experience and previously served as Chief Accounting Officer, and will report directly to the CEO and serve on the Executive Leadership Team.
View raw filing on EDGAR →Ferrari announces the appointment of Massimiliano Di Silvestre as Chief Marketing & Commercial Officer effective July 1, 2026, joining the Leadership Team and reporting to CEO Benedetto Vigna. While the announcement also mentions Enrico Galliera's departure after sixteen years, the principal disclosed action is the appointment of a named executive to a C-suite role. This is material as it affects the composition of Ferrari's senior leadership and the company's strategic direction in marketing and commercial operations.
View raw filing on EDGAR →The filing discloses the appointment of Moncef Slaoui to the Board as a Class II director effective immediately on June 17, 2026, upon recommendation of the Nominating and Corporate Governance Committee. While the section also mentions Jacks Lee's retirement from the Board and his entry into a consulting agreement, the principal disclosed action centers on the new director appointment. Board composition changes are material to investors' assessment of governance and strategic direction.
View raw filing on EDGAR →The exhibit announces the appointment of R. Lynn Atchison to Einride's Board of Directors, subject to shareholder and regulatory approvals. This is a clear executive/governance appointment of a seasoned public company director and financial executive with extensive experience at high-growth technology companies and prior CFO roles. The appointment is material given Atchison's deep expertise, her current board positions at public companies (Bumble, Q2 Holdings), and the company's recent Nasdaq listing, which makes board composition particularly relevant to public market investors.
View raw filing on EDGAR →The Board appointed Adeel Rouf to serve as an independent director and Audit Committee member, effective immediately on June 22, 2026. This is a clear executive appointment under Item 5.02, with detailed disclosure of his qualifications and prior experience in financial services and SPAC transactions. The appointment of a director to a public company's board, particularly to the Audit Committee, is material to investors assessing governance and oversight.
View raw filing on EDGAR →QuidelOrtho appointed Micah Young as Chief Financial Officer effective July 6, 2026, succeeding retiring CFO Joseph M. Busky. Young brings extensive experience from Masimo, NuVasive, and Zimmer Holdings, with a compensation package including a $750,000 base salary, $500,000 sign-on bonus, $6.5M inducement RSU grant, and $5M expected 2027 equity grant.
View raw filing on EDGAR →Roy E. Halyama was appointed President of Burke & Herbert Financial Services Corp. and Burke & Herbert Bank & Trust Company effective July 1, 2026, following the previously announced retirement of H. Charles Maddy, III. While the disclosure mentions both the appointment and the departure, the principal disclosed action centers on Halyama taking the President role—a material executive appointment at a financial services company. The filing explicitly states "No modifications to Mr. Halyama's compensation arrangements were made in connection with his appointment," confirming this is an appointment event rather than a compensation event.
View raw filing on EDGAR →Cincinnati Financial Corporation appointed Lisa M. Franchetti, a retired Admiral and former Chief of Naval Operations (2023–2025), to its board of directors and audit committee, effective immediately, expanding the board to 15 seats.
View raw filing on EDGAR →The news release announces the appointment of Edwin Shadeo as Acting Vice President, Investor Relations and Treasurer, effective immediately. While the release also mentions Emma Chapman's departure, the principal disclosed action is Shadeo's appointment to a named executive officer role. The appointment of a VP-level officer with treasury and investor relations responsibilities is material to a reasonable investor's assessment of the company's leadership and capital markets engagement.
View raw filing on EDGAR →Lauren M. Tyler was elected to Centene's Board of Directors effective June 19, 2026, filling a newly created vacancy as the Board expanded from 9 to 10 members. She was assigned to the Audit Committee and Compensation and Talent Committee, bringing 30+ years of leadership experience including senior roles at JPMorgan Chase and current board service at Cencora and Guardian Life.
View raw filing on EDGAR →Christopher Currier was appointed as Chief Accounting Officer (Principal Accounting Officer) effective June 16, 2026, promoted from Senior Vice President and Controller, succeeding Michael H. Schwerdtman's retirement from the role.
View raw filing on EDGAR →Craig Sasser was appointed Chief Operating Officer effective July 1, 2026, a material C-suite promotion from Regional Vice President, with a base salary of $600,000 and 90% target bonus. Additionally, Briston Blair was promoted to Chief Strategy & Innovation Officer. These senior leadership appointments reflect significant governance and operational changes.
View raw filing on EDGAR →Daniel M. Krawczyk was appointed as Chief Executive Officer and President of Rayonier Advanced Materials, effective June 22, 2026, and concurrently appointed to the Board as a Class III director. The appointment includes compensatory arrangements comprising a base salary of $1,000,000, target bonus of 100%, equity grants totaling $3,300,000, a sign-on bonus of $750,000, and an inducement LPU award of $1,750,000.
View raw filing on EDGAR →The filing announces the appointment of Asad Rahman as Vice President and Chief Financial Officer effective June 30, 2026, with over 25 years of finance and accounting experience from Mars and S.C. Johnson. While the section also discloses David W. Johnson's departure from the CFO role, the principal disclosed action centers on the appointment of the new CFO and his compensatory arrangement ($200,000 restricted stock award). This is material to investors as CFO changes affect financial oversight and governance.
View raw filing on EDGAR →Laura Cockrill was appointed as Executive Vice President and Chief Financial Officer effective June 22, 2026, succeeding Axel André who will depart July 17, 2026. The appointment of a new CFO to this critical C-suite position is material to investors as it affects the company's financial leadership and governance structure.
View raw filing on EDGAR →Joseph H. Jordan was appointed Chief Executive Officer and director of Domino's Pizza, effective October 1, 2026, following a multi-year succession planning process. The appointment follows Russell J. Weiner's transition to Executive Chairman and David A. Brandon's retirement from the Board.
View raw filing on EDGAR →David Morris is appointed Chief Operating Officer (promoted from CFO) and Will Mudd is appointed Chief Financial Officer (promoted from Senior Vice President, Finance), both effective July 1, 2026, as part of the company's executive leadership succession planning.
View raw filing on EDGAR →The press release announces the appointment of Karine Pinto-Flomenboim as Chief Financial Officer of Valens Semiconductor, effective August 9, 2026, succeeding Guy Nathanzon who is stepping down. This is a material executive appointment at the C-suite level (CFO), which would affect a reasonable investor's assessment of the company's leadership and financial stewardship. The disclosure includes her extensive background in semiconductor finance and publicly listed companies, making this a clear exec_appointment event.
View raw filing on EDGAR →The Item 8.01 disclosure centers on the appointment of Dr. Craig Ciesla as Chief Technology Officer (CTO) of IQM Quantum Computers and the transition of Dr. Inés de Vega to Chief Scientist, announced via press release on June 19, 2026. While the filing also references the ongoing business combination with RAAQ, the substantive event disclosed is the executive appointment of Ciesla to a senior leadership role and the role transition of de Vega. This is material as it reflects significant leadership changes at a company preparing for a Nasdaq listing.
View raw filing on EDGAR →The Board elected Mr. Doron Shorrer as a director on June 19, 2026, filling a vacancy created by the non-re-election of Mr. Eitan Ajchenbaum at the 2026 Annual Meeting. Mr. Shorrer was appointed as Audit Committee Chairman and sole member of the Investment Committee.
View raw filing on EDGAR →Dane Neumann was promoted from Executive Vice President and Chief Financial Officer to President and Chief Executive Officer of CVR Energy and its affiliated entities, effective June 18, 2026, and appointed to the Company's Board of Directors.
View raw filing on EDGAR →Peter G. Eames was appointed President and Chief Executive Officer effective August 6, 2026, and nominated to the Board of Directors. Eames, who has served as Vice President of Advanced Technology since 2016, will receive a base salary of $260,000 plus performance-based compensation. This appointment follows the planned retirement of Daniel A. Baker, who has led the company since 2001.
View raw filing on EDGAR →Dane Neumann was promoted from Executive Vice President and Chief Financial Officer to President and Chief Executive Officer of CVR Partners and its general partner, effective June 18, 2026, following Mark Pytosh's resignation.
View raw filing on EDGAR →AXT Inc. appointed Tracy Liu to its Board of Directors as a Class II Director, effective June 17, 2026, expanding the board from four to five members. Ms. Liu, who brings over 30 years of business advisory experience including audit committee leadership at a public semiconductor company, will serve on the audit, compensation, and nominating committees.
View raw filing on EDGAR →Bradley E. Scher was appointed as Chairman, President, and CEO of Pacific Oak Strategic Opportunity REIT, Inc. on June 18, 2026, following the resignations of four directors and Kenneth Yee. The appointment represents a significant leadership transition and includes an engagement letter with Ocean Ridge at $12,500/month total compensation.
View raw filing on EDGAR →The filing discloses multiple executive and board changes on June 16, 2026: resignation of Dionne Pendleton as Director, Corporate Secretary and Treasurer; appointment of Derek Wyman as Director and Treasurer; and appointment of Serge Knazev as Director and Corporate Secretary. While both departures and appointments occur, the principal disclosed actions center on the two new appointments filling vacancies and officer positions, making exec_appointment the most salient classification. The confidence is moderate (0.75) because the filing contains both a departure and multiple appointments, though the appointments are emphasized as the primary reconstitution event.
View raw filing on EDGAR →PagerDuty appointed Eric Prengel as Chief Financial Officer effective June 22, 2026. The appointment was announced via press release and represents a material change in the company's financial leadership.
View raw filing on EDGAR →Dustin J. Semach was appointed to Polaris Inc.'s Board of Directors effective June 19, 2026, as a Class III director and member of the Audit and Compensation Committees. The disclosure centers on the principal action of a person taking a board role. His extensive executive background (current CEO of Sealed Air, former CFO roles at major public companies, 20+ years of experience) and committee assignments make this a material governance event affecting the composition and oversight of the company.
View raw filing on EDGAR →The filing discloses the appointment of Dr. David Young as Chief Operating Officer of CACI International, reporting to the CEO. While the disclosure includes compensatory details (sign-on bonus of $500,000 and $2,000,000 in restricted stock units), the principal action is the appointment of a senior executive to a C-suite role. This is a material executive appointment that would affect investor assessment of the company's leadership and operational direction.
View raw filing on EDGAR →The Board of Directors elected Shoshana M. Vernick as a director effective June 19, 2026, and appointed her to three board committees (Compensation, Finance and Capital Allocation, and Technology and Information Security). The disclosure centers on the appointment of a new director and her committee assignments, making this a clear exec_appointment event. The compensation details provided are incidental to the appointment itself.
View raw filing on EDGAR →The filing discloses the appointment of Douglas Britt to TD SYNNEX's Board of Directors effective June 17, 2026, with assignment to the Audit Committee and Technology Committee. The principal disclosed action is a person taking a governance role. While the disclosure includes standard compensation details for newly appointed non-employee directors, the core event is the board appointment itself, making exec_appointment the most salient classification. This is material as board composition changes affect corporate governance and oversight.
View raw filing on EDGAR →Blair Aiken was elected by the Board effective June 15, 2026 to serve as President, interim CEO, Board Member, and Chairman of the Board. While the filing also discloses that Benjamin Jennings departed as Chairman, the principal disclosed action centers on Aiken's appointment to multiple leadership roles, including the critical interim CEO position. This is material as it represents a significant change in executive leadership during a strategic combination with Rain Cage Carbon, Inc.
View raw filing on EDGAR →